REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT06975787 updates: 1. completion date: 2029-09-09 → 2029-09-10 2. primary completion date: 2029-09-09 → 2029-09-10
Clinical trial NCT06975787 updates: 1. completion date: 2029-09-09 → 2029-09-10 2. primary completion date: 2029-09-09 → 2029-09-10
Clinical trial NCT05572684 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2025-11-01 → 2025-04-30 3. primary completion date: 2025-07-01 → 2025-04-30
Clinical trial NCT04628871 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2030-01-01 → 2026-06-17 3. primary completion date: 2030-01-01 → 2026-06-17 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT04924101: enrollment: 126 → 122 participants.
Clinical trial NCT07641881 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-07-01 → 2026-08-07 3. primary completion date: 2026-07-01 → 2026-07-03 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06955169 updates: 1. status: SUSPENDED → ACTIVE_NOT_RECRUITING 2. enrollment: 153 → 4 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06612268: completion date: 2029-03-12 → 2029-08-12.
Clinical trial NCT06399757: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT07504601: start date: 2026-08-17 → 2026-08-18.
Clinical trial NCT06503406 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-03-01 → 2026-01-08 3. completion date: 2026-10-01 → 2027-12-01 4. primary completion date: 2025-10-01 → 2027-12-01 5. collaborators added: United States Army Institute of Surgical Research 6. collaborators removed: The United States Army Institute of Surgical Research